WADA has suspended the accreditation of the Laboratorio de Control de Dopaje (Laboratory) in Madrid, Spain. The decision, taken by WADA’s President, is a direct result of the WADA Foundation Board’s 19 March decision to declare the Spanish Anti-Doping Agency (AEPSAD) non-compliant.
The suspension, which takes effect immediately, prohibits the Laboratory from carrying out any WADA-related anti-doping activities including all analyses of urine and blood samples.
Pursuant to Article 4.4 of the International Standard for Laboratories (ISL), in order for a laboratory to maintain its accreditation status, the NADO of the country of the laboratory must be Code compliant, as determined by WADA. However, following a revision to ISL rules effective 2 June 2016, WADA may decide not to suspend a laboratory’s accreditation in a case of non-compliance of that country’s NADO if, in the year before the declaration of non-compliance, at least 60% of samples analyzed by that laboratory were provided by Anti-Doping Organizations other than the NADO of the country’s laboratory.
In light of the fact that, between 19 March 2015 and 19 March 2016, 69% of the samples analyzed by the Laboratory were received from AEPSAD, the above-mentioned exception provided for in the ISL does not apply and the Laboratory’s accreditation must be suspended until AEPSAD is declared compliant. Pursuant to Article 13.7 of the World Anti-Doping Code (Code), the Laboratory may appeal this decision to the Court of Arbitration for Sport within 21 days of receipt of notice.